Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oncotarget

Showing results (271-280 of 26,728) with videos related to

Pageof 2,673
Sort By:
Oncotarget|July 10, 2015
Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomasMurielle Grégoire, Fabien Guilloton, Céline Pangault, et al.
Oncotarget|July 10, 2015
Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in ChinaJianguo Zhu, Cong Pan, Jun Jiang, et al.
Oncotarget|July 10, 2015
p53 and rapamycin are additiveBarbara Christy, Marco Demaria, Judith Campisi, et al.
Oncotarget|July 15, 2015
LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2Haiyan Li, Jiahui An, Mengying Wu, et al.
Oncotarget|July 15, 2015
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaDa-Liang Ou, Song-Kun Shyue, Liang-In Lin, et al.
Oncotarget|July 15, 2015
eIF3 controls cell size independently of S6K1-activityKatharina Schipany, Margit Rosner, Loredana Ionce, et al.
Oncotarget|July 15, 2015
Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor typesLaetitia E Lamberts, Derk Jan A de Groot, Rico D Bense, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Oncotarget|July 15, 2015
Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitorsQi Chen, Qi Quan, Lingyu Ding, et al.
Oncotarget|July 15, 2015
Microbial control of intestinal innate immunityMartina Brave, Dana J Lukin, Sridhar Mani
Pageof 2,673

Showing results (271-280 of 26,728) with videos related to

Sort By:
Pageof 2,673
Oncotarget|July 10, 2015
Neutrophils trigger a NF-κB dependent polarization of tumor-supportive stromal cells in germinal center B-cell lymphomasMurielle Grégoire, Fabien Guilloton, Céline Pangault, et al.
Oncotarget|July 10, 2015
Six stroma-based RNA markers diagnostic for prostate cancer in European-Americans validated at the RNA and protein levels in patients in ChinaJianguo Zhu, Cong Pan, Jun Jiang, et al.
Oncotarget|July 10, 2015
p53 and rapamycin are additiveBarbara Christy, Marco Demaria, Judith Campisi, et al.
Oncotarget|July 15, 2015
LncRNA HOTAIR promotes human liver cancer stem cell malignant growth through downregulation of SETD2Haiyan Li, Jiahui An, Mengying Wu, et al.
Oncotarget|July 15, 2015
Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinomaDa-Liang Ou, Song-Kun Shyue, Liang-In Lin, et al.
Oncotarget|July 15, 2015
eIF3 controls cell size independently of S6K1-activityKatharina Schipany, Margit Rosner, Loredana Ionce, et al.
Oncotarget|July 15, 2015
Functional genomic mRNA profiling of a large cancer data base demonstrates mesothelin overexpression in a broad range of tumor typesLaetitia E Lamberts, Derk Jan A de Groot, Rico D Bense, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Oncotarget|July 15, 2015
Continuation of epidermal growth factor receptor tyrosine kinase inhibitor treatment prolongs disease control in non-small-cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitorsQi Chen, Qi Quan, Lingyu Ding, et al.
Oncotarget|July 15, 2015
Microbial control of intestinal innate immunityMartina Brave, Dana J Lukin, Sridhar Mani
Pageof 2,673